Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid‐Dependent Polymyalgia Rheumatica

Among patients with GC-dependent PMR in remission after a six-month TCZ treatment, only a minority of the patients remained relapse-free after TCZ discontinuation. This study suggests that a six-month treatment course is not long enough to withdraw the TCZ. Further studies are needed to determine the optimal TCZ treatment duration and strategies for cessation to prevent relapses.

Authors

Institutions

Publication Details

Journal
Arthritis & Rheumatology
Published
2025-05-07
DOI
https://doi.org/10.1002/art.43221
Citations
2
Primary Topic
Coagulation, Bradykinin, Polyphosphates, and Angioedema
Type
article
Field-Weighted Citation Impact
3.25
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid‐Dependent Polymyalgia Rheumatica

Divi Cornec, Aghiles Souki, Catherine Le Hénaff, Thierry Marhadour et al.
2 citations
Arthritis & Rheumatology
Coagulation, Bradykinin, Polyphosphates, and Angioedema
3.25
article

Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid‐Dependent Polymyalgia Rheumatica

Divi Cornec, Aghiles Souki, Catherine Le Hénaff, Thierry Marhadour, Bruno Fautrel, Baptiste Chevet, Daniel Wendling, Alain Saraux, Marie‐Elise Truchetet, Pascal Hilliquin, Guillermo Carvajal Alegria, Valérie Devauchelle‐Pensec, Christophe Richez, Éric Toussirot, Dewi Guellec, Emmanuelle Dernis, Anne Lohse, Renaud Felten, Guillaume Direz, Benjamin Dervieux, Laurent Chiche, Isabelle Chary‐Valckenaere, Jacques‐Eric Gottenberg, Aleth Perdriger, Emmanuel Nowak
article en
2 citations

Abstract

Among patients with GC-dependent PMR in remission after a six-month TCZ treatment, only a minority of the patients remained relapse-free after TCZ discontinuation. This study suggests that a six-month treatment course is not long enough to withdraw the TCZ. Further studies are needed to determine the optimal TCZ treatment duration and strategies for cessation to prevent relapses.

Arthritis & RheumatologyVol. 77(10)
Université de Bordeaux (FR), Inserm (FR), Université Rennes 2 (FR), Sorbonne Université (FR), Centre Hospitalier Universitaire de Besançon (FR), Methodology and Quality of Life Unit in Oncology (FR), Assistance Publique – Hôpitaux de Paris (FR), Centre Hospitalier Régional et Universitaire de Nancy (FR), Bordeaux Population Health (FR), Centre Hospitalier Sud Francilien (FR), Centre Hospitalier de Mulhouse (FR), Pitié-Salpêtrière Hospital (FR), Centre Hospitalier du Mans (FR), Centre Hospitalier Régional Universitaire de Brest (FR), L'Hôpital Nord Franche-Comté (FR), European Hospital (IT), Centre Hospitalier des Pays de Morlaix (FR), Université de Rennes (FR), Université de Strasbourg (FR)
Good health and well-being
Openalex Percentile: Top 9%
Coagulation, Bradykinin, Polyphosphates, and Angioedema
3.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.